Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Liabilities ₹416 Cr₹407 Cr₹378 Cr₹308 Cr₹184 Cr

What is the latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹416 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹416 Cr
Mar2024₹407 Cr
Mar2023₹378 Cr
Mar2022₹308 Cr
Mar2017₹184 Cr

How is Total Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Liabilities % Change
Mar2025 ₹416 Cr
2.18
Mar2024 ₹407 Cr
7.69
Mar2023 ₹378 Cr
22.58
Mar2022 ₹308 Cr
67.59
Mar2017 ₹184 Cr -

Compare Total Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,317.9 Cr -2.2% 8.3% -22.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,431.0 Cr -0.4% -0.1% -2% Stock Analytics
DIVIS LABORATORIES ₹163,772.0 Cr 0.9% -3% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,884.0 Cr 2% 1.7% 25.2% Stock Analytics
CIPLA ₹107,503.0 Cr -0.9% -7.2% -9.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,798.0 Cr -0.6% 6.8% 2.7% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-2.2%

8.3%

-22.8%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses